Article Details

Roche Cobas 5800, HIV-1 Assay Gets Premarket Approval from FDA | GenomeWeb

Retrieved on: 2022-11-01 14:55:42

Tags for this article:

Click the tags to see associated articles and topics

Roche Cobas 5800, HIV-1 Assay Gets Premarket Approval from FDA | GenomeWeb. View article details on hiswai:

Excerpt

The compact, fully automated system will be commercially available in the fourth quarter of 2022, Roche said.

Article found on: www.genomeweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up